Global Gamma-aminobutyric Acid (GABA) Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch's in-depth investigation and research, the global Gamma-aminobutyric Acid (GABA) market size will reach 120.51 Million USD in 2025 and is projected to reach 186.66 Million USD by 2032, with a CAGR of 6.45% (2025-2032). Notably, the China Gamma-aminobutyric Acid (GABA) market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Gamma-aminobutyric acid, commonly known as GABA, is a neurotransmitter that plays a crucial role in regulating brain activity by inhibiting nerve transmission. It is an amino acid that acts as an inhibitory neurotransmitter in the central nervous system, calming overexcited nerve signals and promoting a state of relaxation. GABA receptors are widely distributed in the brain and are involved in various physiological functions, including anxiety regulation, stress response, and sleep cycles. While GABA is naturally produced in the brain, it is also available as a dietary supplement. Some people use GABA supplements to potentially alleviate stress, anxiety, and promote better sleep, although the effectiveness of such supplements is a subject of ongoing research. GABA's role in maintaining the balance between excitation and inhibition in the brain makes it a crucial component in the complex network of neurotransmitters influencing mental well-being.

The major global  manufacturers of Gamma-aminobutyric Acid (GABA) include Sanofi, Mylan N.V., Teva Pharmaceutical Industries, Novartis, Aytu BioScience, Dr. Reddy’s Laboratories, Endo Pharmaceuticals, Lupin, Johnson & Johnson Services, Sun Pharmaceutical Industries, Lannett, Cipla, Aurobindo Pharma, Zydus Cadila, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Gamma-aminobutyric Acid (GABA). Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Gamma-aminobutyric Acid (GABA) market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Gamma-aminobutyric Acid (GABA) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Gamma-aminobutyric Acid (GABA) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Gamma-aminobutyric Acid (GABA) Include:

Sanofi

Mylan N.V.

Teva Pharmaceutical Industries

Novartis

Aytu BioScience

Dr. Reddy’s Laboratories

Endo Pharmaceuticals

Lupin

Johnson & Johnson Services

Sun Pharmaceutical Industries

Lannett

Cipla

Aurobindo Pharma

Zydus Cadila

Gamma-aminobutyric Acid (GABA) Product Segment Include:

Oral

Parenteral

Intrathecal

Others

Gamma-aminobutyric Acid (GABA) Product Application Include:

Hospital

Specialty Clinic

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Gamma-aminobutyric Acid (GABA) Capacity and Production Analysis

Chapter 3: Global Gamma-aminobutyric Acid (GABA) Industry PESTEL Analysis

Chapter 4: Global Gamma-aminobutyric Acid (GABA) Industry Porter's Five Forces Analysis

Chapter 5: Global Gamma-aminobutyric Acid (GABA) Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis

Chapter 6: Global Gamma-aminobutyric Acid (GABA) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 7: Global Gamma-aminobutyric Acid (GABA) Sales, Revenue, Price and Forecast by Product Type

Chapter 8: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 9: Industrial Chain Analysis, Gamma-aminobutyric Acid (GABA) Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis

Chapter 10: Research Findings and Conclusion

Chapter 11: Methodology and Data Sources